Announcement on Resignation of Non-Executive Director
Filed with SSE · · 2 pages · Chinese
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. on 6ix
Earlier from Biocytogen Pharmaceuticals (Beijing)
Later from Biocytogen Pharmaceuticals (Beijing)
- Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)
- Announcement on the Appointment of Additional Non-Executive Directors and the Adjustment of Members of Special Committees
- Announcement on Expected Increase in Performance for 2025
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Preliminary Earnings Estimate for 2025
Follow Biocytogen Pharmaceuticals (Beijing) into a list and get an email when it puts out news.
Follow Biocytogen Pharmaceuticals (Beijing)